Brain Cancer: Methodist Healthcare will host a live surgical Webcast at Methodist University Hospital Tuesday, February 8, 2005, 4 p.m., showcasing a brain surgery that targets radiation directly to a tumor cavity. The Webcast will feature Allen Sills, MD, neurosurgeon, Methodist University Hospital; assistant professor, department of neurosurgery, The University of Tennessee, Memphis; and the Semmes-Murphey Neurologic and Spine Institute, as he performs a procedure using the GliaSite Radiation Therapy System (RTS). Jon Robertson, MD, neurosurgeon, Methodist University Hospital; professor and chairman, department of neurosurgery, The University of Tennessee, Memphis; and The Semmes-Murphey Neurologic and Spine Institute will narrate the event.
In addition to watching Dr. Sills perform live brain surgery, viewers will learn more about GliaSite RTS and hear from a patient who is being treated with GliaSite RTS as a first-line approach to metastatic brain cancer. Viewers will also be able to e-mail questions to Dr. Robertson and make referrals and appointments.
The patient who is receiving GliaSite RTS during the live Webcast is part of a clinical study being led by Methodist University Hospital which is examining the effectiveness of using GliaSite as an approach to treating tumors that have spread to the brain from other parts of the body. The study involves 10 centers that will analyze the benefits of using the GliaSite RTS to treat patients with newly diagnosed metastatic brain cancer. Dr. Sills along with Allen Redmond, research coordinator, Memphis Regional Brain Tumor Center, wrote the clinical trial.
Allen Sills, Jr., MD
Neuroscience Institute Medical Director
Frederick Boop, MD
Chief of Pediatric Neurosurgery, Le Bonheur Children's Medical Center
